Ovarian characteristics, daily serum progesterone (P4) and estradiol-17 beta (E2) concentrations (d 7 through 17) and uterine luminal secretory protein components and histological variables were evaluated in parous Bos taurus (Angus, n = 20) and Bos indicus (Brahman, n = 19) cows. Cows were slaughtered on d 17 (estrus = d 0) for measurement of ovarian structures, flushing of uteri and removal of uterine tissue for histological evaluation. Cows were placed into one of three reproductive categories: nonpregnant, remnant (flushings contained remnants of embryonic tissue) or pregnant. For ovarian and uterine variables, there were only a few differences among reproductive categories within breeds. For combined categories, weight of the active ovary (containing the corpus luteum) was similar between breeds, but inactive ovarian (P less than .001) and follicular fluid (P less than .01) weights, stromal weight (P less than .01) and number of follicles less than 5 mm in diameter (P less than .01) for both ovaries combined were greater in Brahman than Angus cows. Corpus luteum weight (P less than .001), luteal P4 content (P less than .08) and number of follicles greater than 5 mm in diameter for both ovaries combined (P less than .05) were greater for Angus than for Brahman cows. Overall, mean serum P4 concentrations were greater in nonpregnant (P less than .05), pregnant (P less than .005) and combined (P less than .025) reproductive categories for Angus than corresponding categories of Brahman cows and mean serum E2 concentrations were greater in remnant (P less than .025) and combined (P less than .05) reproductive categories for Angus than corresponding categories of Brahman cows. Mean total uterine luminal protein was greater (P less than .05) in Angus than in Brahman cows for pregnant (23.4 vs 14.7 mg, respectively) and combined reproductive categories (22.4 vs 16.1 mg, respectively). Using electrophoretic analyses, percentage composition of three uterine specific cathode migrating protein bands and quantitative estimates of proteins with molecular weights (MW, X 10(-3)) of 9, 15.5, 34.2, 41.3, 46.2 and 183.1 were greater (P less than .05 to P less than .001) in uterine flushings from Angus than from Brahman cows. Uterine, myometrial and endometrial thicknesses, number of glands/microscopic field and uterine luminal epithelial cell height variables were generally greater (P less than .05 to P less than .001) in pregnant and combined reproductive categories for Angus than for Brahman cows.
Bovine trophoblast protein-1 (bTP-1) is a secreted glycoprotein that consists of several forms differing slightly in mol wt and isoelectric point. It is produced by bovine conceptuses after about day 15 of pregnancy and is believed to play a key role in signalling the presence of an embryo to the mother. In this study, a series of recombinant cDNA clones corresponding to the mRNA for bTP-1 have been isolated from cDNA libraries representing day 18-19 bovine conceptus poly(A)+ mRNA. Base sequencing of several cDNAs indicated that multiple mRNAs for bTP-1 exist. Northern blotting and primer extension experiments showed that the mRNAs average about 1 kilobase in length. One apparently full-length cDNA clone consisted of 1035 bases up to the beginning of the poly(A) tail. It contained an open reading frame of 195 codons which began at a position 79 bases from the 5' end. Its entire sequence was 85% identical to that of a cDNA for the immunologically related ovine trophoblast protein-1 (oTP-1) and about 79% identical to that for a bovine interferon-alpha II (IFN alpha II). The highest conservation of sequence (greater than 90%) was noted in the 3'-untranslated sequences of the bTP-1 and oTP-1 cDNAs. The deduced amino acid sequence of bTP-1 shared 80% identity with oTP-1, between 45-55% with human, rodent, porcine, and bovine IFNs of the alpha 1 subfamily and about 70% with a bovine IFN alpha II. A single potential site for N-glycosylation was noted at Asn78. These results show that bTP-1, like its ovine counterpart oTP-1, is structurally related to the IFN alpha S. We suggest that these embryonic IFNs play a role in controlling immunoreactions at the trophoblast-uterus interface as well as triggering other maternal responses to pregnancy.
Early pregnancy is maintained in ruminants through the actions of conceptus-derived interferon (IFN)-tau on the endometrium. IFN-tau alters uterine release of PGF2", which results in rescue of the corpus luteum and continued release of progesterone. The mechanism of action of IFN-tau includes inhibition of oestradiol receptors, consequent reduction in oxytocin receptors, activation of a cyclooxygenase inhibitor, and a shift in the PGs to favour PGE2 over PGF,,,. IFN-tau also induces several endometrial proteins that may be critical for survival of the developing embryo. One endometrial protein induced by pregnancy and IFN-tau has been identified as bovine granulocyte chemotactic protein-2 (bGCP-2). This chemotactic cytokine (chemokine) has been used as a marker to delineate IFN-tau from IFN-alpha responses in the endometrium. A second protein, called ubiquitin cross-reactive protein (UCRP), resembles a tandem ubiquitin repeat. UCRP becomes conjugated to cytosolic endometrial proteins in response to IFN-tau and pregnancy. Proteins conjugated to UCRP are either modulated or targeted for processing through the proteasome. The action of IFN-tau is mediated by induction of signal transducer and activator of transcription 1 (STAT-1), STAT-2 and interferon regulatory factor 1 (IRF-1) transcription factors. Induction of these transcription factors, the alpha chemokines and UCRP is the prelude to maternal recognition of pregnancy in ruminants.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.